2nd Edition of Cell & Gene Therapy World Conference 2026
Scientific Committee
Raphaël G. Ognar
Raphaël G. Ognar
- Designation: President,CEO,Co-Founder, Chairman,NKILT Therapeutics, Inc.
- Country: USA
Biography
Visionary and charismatic biotech executive with over 28 years of experience spanning commercial strategy, drug development, and product lifecycle management.President, CEO & Co-Founder – Chairman / NKILT Therapeutics, Inc. Raphaël has held key global and regional leadership roles at top-tier pharmaceutical companies including Novartis Oncology, Celgene, and Bristol Myers Squibb, with a 23-year track record of success in Oncology and Hematology. Over the past decade, Raphaël has deepened his focus on Immuno-Oncology and Cell Therapy, culminating in the founding of NKILT Therapeutics, Inc. in 2021. Prior to this, he launched ANIM8 LLC, an executive advisory firm providing strategic and operational consulting for early-stage biotech. Raphaël holds a Master’s degree and a D.E.A. in Physiology and Neurosciences from the University of Bordeaux I & II, as well as an MBA in Strategic Marketing and Enterprise Management from IAE Tours University. Beyond his commitment to advancing cancer therapies, Raphaël is an avid rock climber, vintage wine enthusiast, musician and front man in his family band, and passionate animal rescuer who enjoys traveling the world with family and friends.
Abstract
TBA
The 2nd Edition of Cell & Gene Therapy World Conference (CGTWC 2026) is one of those leading events that would stand high in biology and medical science. CGTWC 2026 will be held in ...
Read More>>
Organizer
